| P2093 | author name string | Helena C Chui | |
| P2860 | cites work | Primary prevention of ischemic stroke | Q22306369 |
| | The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 |
| | Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex | Q29391304 |
| | The thalamus and behavior: effects of anatomically distinct strokes. | Q31046759 |
| | Association, commissural, and projection pathways and their functional deficit reported in literature | Q31058979 |
| | LACUNES: SMALL, DEEP CEREBRAL INFARCTS. | Q33972097 |
| | National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards | Q33998646 |
| | Research criteria for subcortical vascular dementia in clinical trials | Q34015506 |
| | Cerebral microbleeds in CADASIL. | Q34092506 |
| | The Human Periventricular Arterial Blood Supply and the Anatomy of Cerebral Infarctions | Q34229070 |
| | The Significance of Cerebral White Matter Abnormalities 100 Years After Binswanger’s Report | Q34299420 |
| | Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group | Q34349755 |
| | Frontal-subcortical circuits and human behavior | Q34352930 |
| | The neuropsychology of paramedian thalamic infarction. | Q52068298 |
| | Reducing the risk of dementia: efficacy of long-term treatment of hypertension. | Q53257496 |
| | Thalamic infarcts: Clinical syndromes, etiology, and prognosis | Q68352937 |
| | Pathogenesis of Binswanger chronic progressive subcortical encephalopathy | Q70653604 |
| | The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study | Q71588556 |
| | Spectrum of mutations in biopsy-proven CADASIL: implications for diagnostic strategies | Q80357378 |
| | Characterization of risk factors for vascular dementia: the Honolulu-Asia Aging Study | Q34504418 |
| | Longitudinal volumetric MRI change and rate of cognitive decline | Q35677200 |
| | Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease | Q35677208 |
| | Cognitive impact of subcortical vascular and Alzheimer's disease pathology | Q35750397 |
| | MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease | Q35775989 |
| | Ischemic stroke subtypes: a population-based study of incidence rates among blacks and whites | Q35779596 |
| | White matter lesions impair frontal lobe function regardless of their location | Q35844738 |
| | Are lacunar strokes really different? A systematic review of differences in risk factor profiles between lacunar and nonlacunar infarcts | Q36068019 |
| | Neuropathological basis of magnetic resonance images in aging and dementia | Q37057978 |
| | Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease | Q37322618 |
| | Neurobehavioral changes associated with caudate lesions | Q38483418 |
| | Cranial computed tomographic observations in multi-infarct dementia. A controlled study | Q41116243 |
| | Loss of cholinergic pathways in vascular dementia of the Binswanger type. | Q42475931 |
| | Cognitive consequences of thalamic, basal ganglia, and deep white matter lacunes in brain aging and dementia | Q42478217 |
| | Cholinergic neuronal deficits in CADASIL. | Q42504530 |
| | Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial | Q43966701 |
| | The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study | Q44175666 |
| | Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease | Q44438340 |
| | Donepezil in vascular dementia: a randomized, placebo-controlled study | Q44562254 |
| | Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study | Q44734507 |
| | Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study | Q45166675 |
| | Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial | Q45251456 |
| | Risk factors for ischemic stroke subtypes: the Atherosclerosis Risk in Communities study | Q46416541 |
| | Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects | Q46505854 |
| | Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy | Q46689556 |
| | Statins and cognitive function in the elderly: the Cardiovascular Health Study | Q46794954 |
| | Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease | Q46874702 |
| | Dementia following strokes in the mesencephalon and diencephalon | Q48186182 |
| | Senile dementia of the Binswanger type. A vascular form of dementia in the elderly | Q48195801 |
| | Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial | Q48359732 |
| | Why do frontal lobe symptoms predominate in vascular dementia with lacunes? | Q48368845 |
| | Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome? | Q48425564 |
| | Nonhaemorrhagic thalamic infarction. Clinical, neuropsychological and electrophysiological findings in four anatomical groups defined by computerized tomography | Q48482381 |
| | Hypertension and cerebral white matter lesions in a prospective cohort study | Q48651384 |
| | An autopsy study of the incidence of lacunes in relation to age, hypertension, and arteriosclerosis | Q48681208 |
| | The pattern of cognitive performance in CADASIL: a monogenic condition leading to subcortical ischemic vascular dementia | Q48709532 |
| | Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study | Q48830241 |
| | Cerebral small-vessel disease and decline in information processing speed, executive function and memory | Q48860735 |
| | Longitudinal study of blood pressure and white matter hyperintensities: the EVA MRI Cohort | Q48923423 |
| | Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephaloapthy (CADASIL): a hereditary cerebrovascular disease, which can be diagnosed by skin biopsy electron microscopy | Q48950237 |
| | MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL. | Q48955726 |
| | Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study | Q48958955 |
| | Features of the cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study | Q49012909 |
| | Short-term predictors of incident stroke in older adults. The Cardiovascular Health Study. | Q51012830 |
| | Damage within a network of white matter regions underlies executive dysfunction in CADASIL. | Q51987051 |
| | Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. | Q52061053 |
| P433 | issue | 3 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 717-40, vi | |
| P577 | publication date | 2007-08-01 | |
| P1433 | published in | Neurologic Clinics | Q15756619 |
| P1476 | title | Subcortical ischemic vascular dementia | |
| P478 | volume | 25 | |